|
|
| 
|
| 2001 Grants |
| Investigator |
Institution |
Project Title |
Grant Duration |
Amt Granted |
| Sergei Atamas,
M.D., Ph.D. |
University of
Maryland School of Medicine
Baltimore, Md. |
Mechanisms of
Synergy Between CD40 Ligation and IL-4 in Fibroblasts |
One Year |
$50,000 |
| Richard Bucala, M.D., Ph.D. |
The Picower Institute for
Medical Research
New York, N.Y. |
Role of Peripheral Blood
Fibrocytes in the Pathogenesis of Scleroderma |
Two Years |
$100,000 |
| Stephen Clark, Ph.D. |
University of Connecticut
Health Center
Farmington, Conn. |
Studies of Collagen Synthesis
in the Tight Skin Mouse |
One Year |
$60,000 |
| Mario Del Rosso, M.D. |
University of Florence
Florence, Italy |
Angiogenesis in Systemic
Sclerosis: role of the plasminogen activation system |
Two Years |
$100,000 |
| Asish Ghosh, Ph.D. |
University of Illinois at
Chicago
Chicago, Ill. |
Regulation of Type I Collagen
Gene Expression by Tumor Suppressor Gene p53: Implication
in Scleroderma |
Two Years |
$89,671 |
| Bashar Kahaleh, M.D. |
Medical College of Ohio Toledo,
Ohio |
Endothelial Gene Expression
in Scleroderma |
Two Years |
$100,000 |
| Nathalie Lambert, Ph.D. |
Fred Hutchinson Cancer Research
Center
Seattle, Wash. |
Microchimerism in the pathogenesis
of systemic sclerosis |
Two Years |
$100,000 |
| Shinsuke Takagawa, M.D. |
University of Illinois at
Chicago
Chicago, Ill. |
Role of Smad Signaling in
a Model of Scleroderma |
Two Years |
$100,000 |
| Maria Trojanowska, Ph.D. |
Medical University of South
Carolina
Charleston, S.C. |
The role of Ets factors in
the mechanism of fibrosis |
Two Years |
$100,000 |
| Barbara White, M.D. |
Baltimore VA Medical Center
Baltimore, M.D. |
Chemokines and lung Fibrosis
in Scleroderma |
Two Years |
$100,000 |
| |
|
Total Granted 2001: |
|
$899,671 |
|
| All
grants funded by the Scleroderma Foundation. |
Back
to Our Researchers |
|
|
|
|
